pharmaceutical preparations, namely pharmaceutical preparations for the treatment of alzheimer's disease, anxiety disorders, atopic dermatitis, autoim Read More

Classification Information

Class [005]
Pharmaceutical preparations, namely pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders, namely anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders, namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders, namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders, namely Huntington's disease, Alzheimer's disease, dementia and Parkinson's disease, neurological disorders, namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; Radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification kind code

Mark Details

Serial Number

1845519

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 15^th Feb 2019	Allowed
Submitted for opposition 51 on 15^th Feb 2019	Allowance Notice Sent
Submitted for opposition 42 on 31^st Oct 2018	Advertised
Submitted for opposition 26 on 11^th Oct 2018	Approved
Submitted for opposition 27 on 22^nd Aug 2018	Approval Notice Sent
Submitted for opposition 22 on 05^th Apr 2018	Search Recorded
Submitted for opposition 20 on 05^th Apr 2018	Examiner's First Report
Submitted for opposition 31 on 06^th Jul 2017	Formalized
Submitted for opposition 1 on 04^th Jul 2017	Created
Submitted for opposition 30 on 30^th Jun 2017	Filed